Jove
Visualize
Contact Us

Related Experiment Videos

Emerging therapies for female sexual dysfunction.

Robert Taylor Segraves1

  • 1Department of Psychiatry, MetroHealth Medical Center, 2500 Metrohealth Drive, Cleveland, Ohio 44109-1998, USA. Rsegraves@metrohealth.org

Expert Opinion on Emerging Drugs
|December 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Which Emperor Has New Clothes? Biology Versus Psychology in the Era of Statistical Magic.

Journal of sex & marital therapy·2016
Same author

Editorial Comment on "The Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction".

The journal of sexual medicine·2015
Same author

Antidepressant-induced sexual dysfunction in men.

Pharmacology, biochemistry, and behavior·2013
Same author

Encompassing sexual medicine within psychiatry: pros and cons.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2010
Same author

Considerations for diagnostic criteria for erectile dysfunction in DSM V.

The journal of sexual medicine·2010
Same author

Considerations for an evidence-based definition of premature ejaculation in the DSM-V.

The journal of sexual medicine·2010
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Female sexual dysfunction affects many women, with low desire being common. While some treatments show promise, like testosterone for libido and bupropion for orgasm, effective options remain limited.

Area of Science:

  • Reproductive Health
  • Pharmacology
  • Clinical Medicine

Background:

  • Female sexual dysfunction (FSD) affects a significant portion of women, with low sexual desire being the most prevalent complaint.
  • Other common FSD issues include difficulties with orgasm, lubrication, and painful intercourse.
  • Current treatment landscape includes devices like vacuum erection devices but lacks approved pharmacological agents for FSD.

Purpose of the Study:

  • To review the current state of treatment for female sexual dysfunction.
  • To evaluate the efficacy and safety of various therapeutic approaches, including pharmacological and non-pharmacological interventions.
  • To identify gaps in current research and treatment strategies for FSD.

Main Methods:

  • Review of epidemiological data on FSD prevalence.

Related Experiment Videos

  • Analysis of clinical trial data for pharmacological agents (e.g., phosphodiesterase inhibitors, androgens, bupropion) and devices.
  • Assessment of the correlation between subjective and objective measures of sexual arousal in women.

    • Main Results:

    • Vacuum erection devices are approved for increasing clitoral blood flow.
    • Phosphodiesterase inhibitors show minimal clinical efficacy despite increasing genital vasocongestion.
    • Supraphysiological doses of testosterone effectively increase libido in postmenopausal women, but long-term safety is unknown.
    • Bupropion may improve orgasm attainment in women with hypoactive sexual desire disorder.

    Conclusions:

    • Effective pharmacological treatments for FSD remain limited, highlighting a significant unmet medical need.
    • Androgen therapy shows potential for libido enhancement but requires further safety evaluation.
    • Bupropion presents a potential central nervous system-targeted option for specific FSD symptoms like anorgasmia.
    • Further research is needed to develop safe and effective treatments for the diverse range of female sexual dysfunctions.